Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The Centers for Medicare and Medicaid Services announced in July ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.

Pain in sickle cell disease is frequently misunderstood, leading to mistrust between patients and providers. Many patients report managing their pain crises at home, because they fear being dismissed, ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed what they called “alarming” underutilization of disease-modifying therapies for sickle cell ...

When it comes to reproductive autonomy, the stakes are already high. But what happens when a complex medical condition like sickle cell disease (SCD) enters the equation? STAT’s analysis of ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

India, Dec. 22 -- Around 1.65 crore persons have been screened for sickle cell disease so far in Chhattisgarh and their details have been registered in the Union Government's portal, officials said on ...